AEON Biopharma (AEON) Notes Payables (2022)
AEON Biopharma (AEON) posted Notes Payables of $70.9 million for Q4 2022.
AEON Biopharma (AEON) Notes Payables (2022) Analysis & Trends
AEON Biopharma has reported Notes Payables for 1 years, with the latest figure at $70.9 million in Q4 2022.
- Quarterly Notes Payables changed N/A year-over-year to $70.9 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $70.9 million (changed N/A YoY) and the FY2022 annual result came in at $70.9 million, changed N/A from the prior year.
- Notes Payables was little changed at $70.9 million in Q4 2022 per AEON's latest filing.
- Over five years, Notes Payables peaked at $70.9 million in Q4 2022 and troughed at $70.9 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - |
| 10 | AEON Biopharma | 9.88 Mn | 6.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 70.87 Mn |